DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151405

Visual evoked potential changes in patients with diabetes mellitus without retinopathy

Sangeeta Gupta, Gaurav Gupta, V.K. Deshpande

Abstract


Background: Diabetes mellitus is a metabolic disorder, associated with a great deal of morbidity in the patients due its chronic complications including diabetic retinopathy. Visual evoked potentials (VEPs), which assess the functional integrity of the visual functions from retina to visual cortex, can prove to be a sensitive tool to study the possible effects that diabetes may exert on the visual system. In patients without clinically evident retinopathy, electrophysiological evidence of visual dysfunction can help in early detection of the visual involvement. Hence, this study attempted to detect the presence of such visual dysfunctions in the diabetics without retinopathy by pattern- reversal visual evoked potentials (PRVEPs).

Methods: PRVEP was recorded in 116 subjects (64 diabetics without retinopathy and 52 controls). P100 latency, N75-P100 amplitude and interocular latency differences were compared between the diabetics and the controls. The parameters were compared among the groups with different duration of the disease as well as those with different glycaemic status.

Results: The study has demonstrated significant prolongation of mean P100 latency, reduction in N75-P100 amplitudes and increased interocular latency difference in the diabetics as compared to the control group. The duration of the illness was found to alter the mean P100 latency while the glycaemic status of the diabetics was not found to be correlated with the PRVEP abnormalities.

Conclusions: VEP responses are deranged in diabetic patients before the development of retinopathy. VEP measurements can be used for the early diagnosis of visual dysfunctions in the diabetes for a better prognosis of the condition.

 


Keywords


Diabetes mellitus, Visual evoked potentials

Full Text:

PDF

References


Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524–31.

REF Namperumalsamy P. Guidelines for Diabetic Retinopathy screening in a large population. Retina today. 2008:44-7.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.

Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number Ophthalmology.1991;98:766-85.

The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981;88(7):583-600.

Fong DS, Aiello L, Gardener TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in Diabetes. Diabetes care Suppl. Jan 2004;27:84-6.

Diabetes Fact Sheet N°312, World health organization,2008.http://www.who.int/mediacentre/factsheets/fs 312/en/.

Ewing FME, Deary IJ, Strachan MWJ, Frier BM. Seeing Beyond Retinopathy in Diabetes:Electrophysiological and Psychophysical Abnormalities and Alterations in Vision. Endocrine Reviews.1998;19(4):462-76.

Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormene AP, Vaegan. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 2010;120:111-9.

Karlica D, Galetović D, Ivanisević M, Skrabić V, Znaor L, Jurisić D. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I. CollAntropol. 2010;34(2):525-9.

American Clinical Neurophysiology Society. Guideline 9B: Guidelines on VisuaL Evoked Potentials. J Clin Neuophysiol . 2006;23(2):138-56.

Lieth E, Gardner TW, Barber AJ, Antonetti DA; Penn State Retina Research Group.Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol. 2000;28:3-8.

Sivakumar R, Ravindran G, Muthayya M, Lakshminarayanan S, Velmurughendran CU. Diabetic retinopathy analysis. J Biomed Biotechnol. 2005;2005(1):20-7.

Yaltkaya K, Balkan S et al. Visual evoked potentials in diabetes mellitus. Acta Neurol Scand. 1988;77(3): 239-41.

Moreo G, Mariani E. et al. Visual evoked potentials in NIDDM: A longitudinal study. Diabetologia. 1995;38:573-6.

Dolu H, Ulas UH, Bolu E.Evaluation of central neuropathy in type II diabetes mellitus bymultimodal evoked potentials. Acta Neurol Belg. 2003; 103(4):206-11.

Heravian J, Ehyaei A, Shoeibi N, Azimi A, Ostadi-Moghaddam H, Yekta AA et al. Pattern Visual Evoked Potentials in Patients with Type II Diabetes Mellitus. J Ophthalmic Vis Res. 2012;7(3):225-30.

Chopra D, Gupta M, Manchanda KC, Sharma RS, Sidhu RS. A Study of Visual Evoked Potentials in Patients of Type-2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2011;5(3):519-22.

Lopes de Faria JM, Katsumi O, Cagliero E, Nathan D, Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol. 2001;239(9):643-8.

Pan CH, Chen SS. Pattern shift visual evoked potentials in diabetes mellitus. Gaoxiong Yi Xue Ke Xue Za Zhi. Jul 1992;8(7):374-83.

Parisi V, Uccioli L, Monticone G, Parisi L, Durola L, Pernini C et al.Visual evoked potentials after photostress in newly diagnosed insulin-dependent diabetes patients. Graefes Arch Clin Exp Ophthalmol. 1995;233(10):601-4.

Raman PG, Sodani V, George B. A study of visual evoked potential changes in diabetes mellitus. Int. J. Diab. Dev. Countries. 1997;17:69-73.

Verrotti A, Lobefalo L, Trotta D, Della Loggia G, Chiarelli F, Luigi C et al. Visual evoked potentials in young persons with newly diagnosed diabetes: a long-term follow-up. Dev Med Child Neurol. 2000; 42(4):240-4.

Pierzchala K, Kwiecinski J. Blood flow in ophthalmic artery and visual evoked potentials in diabetic patients. Wiad Lek. 2002;55(3-4):183-8.

Shenoy R, Al-Belushi H, Al-Ajmi S et al. Visually evoked potentials after panretinal photocoagulation in omani patients with uncontrolled diabetes mellitus. Middle East African Journal of Ophthalmology. 2008;15(2):51-6.

Parisi V, Uccioli L, Monticone G, Parisi L, Manni G, Ippoliti D et al. Electrophysiological assessment of visual function in IDDM patients. Electroencephalogr Clin Neurophysiol. 1997; 104(2):171-9.

Parisi V, Uccioli L, Parisi L,Colacino G, Manni G, Menzinger G et al. Neural conduction in visual pathways in newly-diagnosed IDDM patients. Electroencephalogr Clin Neurophysiol.1998; 108(5):490-6.

Trick GL, Burde RM,Gordon MO, Kilo C, Santiago JV. Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials. Documenta Ophthalmologica .1988;70(1):19-28.

Sima AA, Lattimer SA, Yagihashi S, Greene DA. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest. 1986;77(2):474-84.

Greene DA, Chakrabarti S, Lattimer SA, Sima AA. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. J Clin Invest. 1987;79(5):1479-85.

Kamijo M, Cherian PV, Sima AA. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat. Diabetologia. 1993; 36(10):893-8.

Azal O, Özkardeş A, Önde ME, Özata M, Özişik G, Çorakçi A, Gündoğan MA. Visual evoked potentials in Diabetic patients. Tr. J of Medical Sciences. 1998; 28:139-42.

Anastasi M, Lauricella M, Giordano C, Galluzzo A. Acta Diabetol Lat. Visual evoked potentials in insulin-dependent diabetics. 1985; 22(4):343-9.

Comi G, Martinelli V, Galardi G, Medaglini S, Poggi A, Beccaria L et al. Visual evoked potentials in diabetic teen- agers: influence of metabolic control and relationship with peripheral neuropathy. Metabolic, Pediatric, and Systemic Ophthalmology (New York, N.Y : 1985).1986, 9(2-4):85-87.

Puvanendran K, Devathasan G, Wong PK. Visual evoked responses in diabetes. Journal of Neurology, Neurosurgery, and Psychiatry.1983;46:643-7.

Comi G, Martinelli V, Galardi G, Medaglini S, Beccaria L, Meschi F et al. Evaluation of central nervous conduction by visual evoked potentials ininsulin-dependent diabetic children. Metabolic and clinical correlations. Acta Diabetol Lat. 1987; 24(2):157-62.

Pozzessere G1, Rizzo PA, Valle E, Mollica MA, Meccia A, Morano S et al.Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care. 1988J;11(6):473-80.

Martinelli V, Piatti PM, Filippi M, Pacchioni M, Pastore MR, Canal N et al. Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients. Acta Diabetol. 1992;29(1):34-7.

Ziegler O, Guerci B, Algan M, Lonchamp P, Weber M, Drouin P. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care. 1994;17(10):1141-7.

Szabela DA, Loba J, Pałenga-Pydyn D, Tybor K, Ruxer J, Split W. The picture of visual evoked potentials in type 2 diabetes mellitus. Klin Oczna. 2005;107(7-9):498-501.